Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: J Matern Fetal Neonatal Med. 2010 Aug;23(8):794–805. doi: 10.3109/14767050903443467

Figure 3.

Figure 3

Amniotic fluid concentrations of sVEGFR-1 in the control group, unexplained fetal death, fetal death with preeclampsia and/or placental abruption, and fetal death with chromosomal or congenital anomalies. Unexplained fetal death (median 442 ng/ml, range 84-2,366 ng/ml), fetal death with preeclampsia and/or placental abruption (median 202 ng/ml, range 83-830 ng/ml) and fetal death with major chromosomal and/or congenital anomalies (median 289 ng/ml, range 96-567 ng/ml) had a significantly higher median amniotic fluid concentration of sVEGFR-1 than the control group (median 85.1 ng/ml, range 0.1-595.6 ng/ml; p<0.001, p=0.04 and p=0.004; respectively). The results remained significantly different after adjusting for multiple comparisons using Holm method (p<0.001, 0.04 and 0.008 respectively). The y-axis is in logarithmic scale. * p<0.05.